191 related articles for article (PubMed ID: 25120143)
1. From epidemiology and genetics to diagnostics, outcome measures, and novel treatments in autoimmune bullous diseases.
Ludwig RJ; Borradori L; Diaz LA; Hashimoto T; Hertl M; Ibrahim SM; Jonkman MF; Kitajima Y; Murrell DF; Schmidt E; Shimizu H; Stanley JR; Woodley DT; Zillikens D
J Invest Dermatol; 2014 Sep; 134(9):2298-2300. PubMed ID: 25120143
[No Abstract] [Full Text] [Related]
2. Management of autoimmune bullous diseases in France: a nationwide network of 30 centers.
Meyer N; Paul C; Joly P
Dermatol Clin; 2011 Oct; 29(4):659-62. PubMed ID: 21925014
[TBL] [Abstract][Full Text] [Related]
3. Management of autoimmune blistering diseases in Spain.
Suárez R; España A; Herrero-González JE; Iranzo P; Mascaró JM
Dermatol Clin; 2011 Oct; 29(4):673-6. PubMed ID: 21925016
[TBL] [Abstract][Full Text] [Related]
4. The Regibul Register: A Tool for Monitoring the Distribution and Incidence of Autoimmune Bullous Dermatoses in Three French Regions, 2010 to 2015.
Loget J; Barbe C; Duvert-Lehembre S; Bédane C; Maizières M; Joly P; Couraud A; Plée J; Bernard P
Acta Derm Venereol; 2018 Mar; 98(3):380-381. PubMed ID: 29136267
[No Abstract] [Full Text] [Related]
5. Autoimmune bullous diseases in pregnancy: clinical and epidemiological characteristics and therapeutic approach.
Fagundes PPS; Santi CG; Maruta CW; Miyamoto D; Aoki V
An Bras Dermatol; 2021; 96(5):581-590. PubMed ID: 34304937
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of Autoimmune Bullous Diseases in Northern Greece. A 4-year Retrospective Study and Review of the Literature.
Patsatsi A; Lamprou F; Kokolios M; Stylianidou D; Trigoni A; Kalampalikis D; Sotiriadis D
Acta Dermatovenerol Croat; 2017 Oct; 25(3):195-201. PubMed ID: 29252171
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune blistering diseases: incidence and treatment in Croatia.
Marinovic B; Lipozencic J; Jukic IL
Dermatol Clin; 2011 Oct; 29(4):677-9. PubMed ID: 21925017
[TBL] [Abstract][Full Text] [Related]
8. Survey of the epidemiology of autoimmune bullous disorders in Peking Union Medical College Hospital: a 30-year review.
Wang YL; Tie D; Yan TM; Li L; Jin HZ; Sun Q; Zuo YG
Eur J Dermatol; 2017 Jun; 27(3):331-332. PubMed ID: 28524049
[No Abstract] [Full Text] [Related]
9. Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations.
Kridin K
Immunol Res; 2018 Feb; 66(1):6-17. PubMed ID: 29159697
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune bullous diseases in Austria.
Laimer M; Pohla-Gubo G; Kraus L; Nischler E; Bauer JW; Ahlgrimm-Siess V; Hintner H
Dermatol Clin; 2011 Oct; 29(4):691-8. PubMed ID: 21925021
[TBL] [Abstract][Full Text] [Related]
11. Immunoadsorption in dermatology.
Meyersburg D; Schmidt E; Kasperkiewicz M; Zillikens D
Ther Apher Dial; 2012 Aug; 16(4):311-20. PubMed ID: 22817118
[TBL] [Abstract][Full Text] [Related]
12. Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic.
Kasperkiewicz M; Schmidt E; Amagai M; Fairley JA; Joly P; Murrell DF; Payne AS; Yale ML; Zillikens D; Woodley DT
J Eur Acad Dermatol Venereol; 2021 Jul; 35(7):e412-e414. PubMed ID: 33655539
[No Abstract] [Full Text] [Related]
13. Linear IgA bullous disease of childhood: an experience from Kuwait.
Nanda A; Dvorak R; Al-Sabah H; Alsaleh QA
Pediatr Dermatol; 2006; 23(5):443-7. PubMed ID: 17014638
[TBL] [Abstract][Full Text] [Related]
14. [Criteria of the French bullous study group for day-care hospitalization billing for a patient with autoimmune bullous disease].
Ingen-Housz-Oro S; Joly P; Prost C; Delaporte E; Le Roux C; Richard MA;
Ann Dermatol Venereol; 2016 Dec; 143(12):857-859. PubMed ID: 27364898
[No Abstract] [Full Text] [Related]
15. [Autoimmune bullous skin diseases].
Vaillant L; Meunier L
Ann Dermatol Venereol; 1997; 124(1):46-56. PubMed ID: 9686044
[No Abstract] [Full Text] [Related]
16. [Optimizing therapy in patients with severe autoimmune blistering skin diseases].
Schmidt E
Hautarzt; 2009 Aug; 60(8):633-40. PubMed ID: 19536513
[TBL] [Abstract][Full Text] [Related]
17. Management of autoimmune bullous diseases: pharmacology and therapeutics.
Ahmed AR
J Am Acad Dermatol; 2013 Sep; 69(3):476-7. PubMed ID: 23957968
[No Abstract] [Full Text] [Related]
18. [Practical management of the most common autoimmune bullous diseases].
Suárez-Fernández R; España-Alonso A; Herrero-González JE; Mascaró-Galy JM
Actas Dermosifiliogr; 2008; 99(6):441-55. PubMed ID: 18558052
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune bullous diseases: diagnosis and management.
Mutasim DF
Dermatol Nurs; 1999 Feb; 11(1):15-21; quiz 22-3. PubMed ID: 10670322
[TBL] [Abstract][Full Text] [Related]
20. [Combined immunosuppressive therapy of autoimmune bullous dermatoses].
Grando SA
Sov Med; 1988; (2):113-5. PubMed ID: 3291136
[No Abstract] [Full Text] [Related]
[Next] [New Search]
